Stem Cell Source Market
Global Stem Cell Source Market Size, Share & Trends Analysis Report by Type (Allogeneic, and Autologous), and by Application (Research, Therapeutics, Oncology, Musculoskeletal Disorder, Blood Disorder, Autoimmune Disease, and Others) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global stem cell source market is anticipated to grow at a significant CAGR of 15.5% during the forecast period. The increasing prevalence of chronic diseases aided the growth of the stem cell therapy market. Long working hours, insufficient physical activity, and unhealthy eating and drinking habits all contributes to the prevalence of chronic diseases, driving the need for stem cell therapy. According to a United Nations article, the proportion of global deaths caused by chronic diseases is expected to rise to 70% of total deaths by 2030. The global burden of chronic diseases is expected to be around 60% in upcoming years. Companies in the stem cell therapy market are increasingly focusing on strategic alliances. For instance, in September 2018, CRISPR Therapeutics, a biotechnology company that develops transformative medicine for serious diseases using the gene-editing platform, and ViaCyte, a regenerative medicine company based in California, have collaborated on the development and marketing of stem cell transplantation stem cell therapies for diabetes treatment. Moreover, the increasing funding for stem cell research for development of therapies for the treatment of autoimmune, neurological, and cardiovascular diseases and increasing number of clinical trials are projected to drive the market growth.
Impact of COVID-19 Pandemic on Global Stem Cell Source Market
The global stem cell source market has declined primarily as a result of the COVID-19 outbreak, which has resulted in restrictive containment measures such as social distancing, remote working, and the closure of industries and other commercial activities, all of which have resulted in operational challenges. Concerns about cells-derived stem cells halted the global market's growth, as research with these cells requires disrupting an artificially-fertilized embryo at the 5-14 day stage.
Segmental Outlook
The global stem cell source market is segmented based on the type, and application. Based on the type, the market is segmented into allogeneic and autologous. Based on the application, the market is sub-segmented into cardiovascular diseases surgeries , inflammatory & autoimmune diseases , neurological disorders , musculoskeletal disorder, neurological disorders, , autoimmune disease, and others (wounds and injuries, cancer)..
Global Stem Cell Source Market Share by Type, 2021 (%)
The Allogeneic Stem Cell Therapy Segment is Anticipated to Hold a Prominent Share in the Global Stem Cell Source Market
. The allogeneic stem cell therapy segment held the largest share of the stem cell therapy market in 2021. It is expected that the segment is again going to hold prominent share in the market. The low complexities involved in manufacturing allogeneic-based therapies account for the large share of this segment. Theincrease in the number of clinical trials in the production of allogeneic-based products is further expected to drive the segment growth.
Regional Outlooks
The global stem cell source market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). North America region is likely to highest share in the market during the forecast period. The increasing public-private funding and research grants for stem cell therapies and increasing number of cancer cases are the key factors providing ample opportunities to the market growth.
Global Stem Cell Source Market Growth, by Region 2022-2028
The Asia-Pacific Region is estimated to be the fastest growing in the Global Stem Cell Source Market
The Asia-Pacific is anticipated to hold a prominent share and expected to show the fastest growth. The major economies such as China, India, Japan are contributing prominent share to the market growth. The regional growth is attributed to the government’s increasing efforts in strengthening the biotech industry, continual modernization of the healthcare sector, and rising public and private initiatives to influence the use of stem cell treatments. Moreover, the surge in the awareness about the importance of stem cell therapies in treating terminal conditions is also majorly influencing the market growth.
Market Players Outlook
The major companies serving the global Stem Cell Source market include Smith & Nephew PLC, MEDIPOST Co., Ltd., Anterogen Co., Ltd., PHARMICELL Co., Ltd., JCR Pharmaceuticals Co., Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2019, Vertex Pharmaceuticals Inc, a biopharmaceutical company based in the US, announced the purchase of Semma Therapeutics, a private biotechnology company, for $950 million. The acquisition is expected to be consistent with Vertex's strategy of investing in scientific innovation that results in transformative medicine for patients suffering from serious diseases. Semma Therapeutics is a company based in the United States that uses stem cell therapy to treat diabetes.
The Report Covers
- Market value data analysis of 2022 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Stem Cell Source market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Stem Cell Source Market
• Recovery Scenario of Global Stem Cell Source Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Smith & Nephew plc
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. MEDIPOST Co., Ltd
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Anterogen Co., Ltd
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. JCR Pharmaceuticals Co., Ltd
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. PHARMICELL Co., Ltd.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Stem Cell Source Market by Type
4.1.1. Allogeneic
4.1.2. Autologous
4.2. Global Stem Cell Source Market by Application
4.2.1. Cardiovascular Diseases Surgeries
4.2.2. Inflammatory & Autoimmune Diseases
4.2.3. Neurological Disorders
4.2.4. Musculoskeletal Disorder
4.2.5. Neurological Disorders,
4.2.6. Autoimmune Disease
4.2.7. Others (Wounds and Injuries, Cancer)
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Moderna, Inc
6.2. Intellia Therapeutics, Inc.,
6.3. Advanced Cell Technology, Inc.
6.4. Anavex Life Sciences Corp.
6.5. Becton, Dickinson and Co
6.6. BioNTech SE
6.7. BioRestorative Therapies
6.8. BrainStorm Cell Therapeutic
6.9. Celldex Therapeutics, Inc.
6.10. Cellect Biotechnology Ltd.
6.11. Cellular Biomedicine Group
6.12. Enochian Biosciences
6.13. Holostem Terapie Avanzate S.r.l
6.14. International Stem Cell Corp
6.15. JCR Pharmaceuticals
6.16. Kangstem Biotech
6.17. Merck KGaA
6.18. Ocugen,Inc.
6.19. Pluristem Therapeutics
6.20. Protagonist Therapeutics, Inc.,
6.21. Prothena Corp.,
6.22. Qiagen NV
6.23. Regrow Biosciences
6.24. ReNeuron Group plc
6.25. RTI Surgical
6.26. Takeda Pharmaceutical Company
6.27. Thermo Fisher Scientific
1. GLOBAL STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL ALLOGENEIC STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL AUTOLOGOUS IN STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
5. GLOBAL STEM CELL SOURCE IN CARDIOVASCULAR DISEASES SURGERIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
1. GLOBAL STEM CELL SOURCE IN INFLAMMATORY & AUTOIMMUNE DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
2. GLOBAL STEM CELL SOURCE IN NEUROLOGICAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL STEM CELL SOURCE IN MUSCULOSKELETAL DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL STEM CELL SOURCE IN NEUROLOGICAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL STEM CELL SOURCE IN AUTOIMMUNE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL STEM CELL SOURCE IN OTHERS (WOUNDS AND INJURIES, CANCER) MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
8. NORTH AMERICAN STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
9. NORTH AMERICAN STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
10. NORTH AMERICAN STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
11. EUROPEAN STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. EUROPEAN STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
13. EUROPEAN STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
14. ASIA-PACIFIC STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. ASIA-PACIFIC STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. REST OF THE WORLD STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. REST OF THE WORLD STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
19. REST OF THE WORLD STEM CELL SOURCE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL STEM CELL SOURCE MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL STEM CELL SOURCE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL STEM CELL SOURCE MARKET, 2021-2027 (%)
4. GLOBAL STEM CELL SOURCE MARKET SHARE BY TYPE, 2020 VS 2027 (%)
5. GLOBAL ALLOGENEIC IN STEM CELL SOURCE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
6. GLOBAL AUTOLOGOUS IN STEM CELL SOURCE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
7. GLOBAL STEM CELL SOURCE MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
8. GLOBAL STEM CELL SOURCE IN CARDIOVASCULAR DISEASES SURGERIES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
9. GLOBAL STEM CELL SOURCE IN INFLAMMATORY & AUTOIMMUNE DISEASES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
10. GLOBAL STEM CELL SOURCE IN NEUROLOGICAL DISORDERS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
11. GLOBAL STEM CELL SOURCE IN MUSCULOSKELETAL DISORDER MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
12. GLOBAL STEM CELL SOURCE IN NEUROLOGICAL DISORDERS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
13. GLOBAL STEM CELL SOURCE IN AUTOIMMUNE DISEASE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
14. GLOBAL STEM CELL SOURCE IN OTHERS (WOUNDS AND INJURIES, CANCER) MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
15. GLOBAL STEM CELL SOURCE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
16. US STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
17. CANADA STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
18. UK STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
19. FRANCE STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
20. GERMANY STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
21. ITALY STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
22. SPAIN STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
23. REST OF EUROPE STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
24. INDIA STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
25. CHINA STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
26. JAPAN STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
27. SOUTH KOREA STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF ASIA-PACIFIC STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF THE WORLD STEM CELL SOURCE MARKET SIZE, 2021-2028 ($ MILLION)
